±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 484  |  »Ø¸´: 1

springsunyj

ÖÁ×ðľ³æ (ÎÄѧ̩¶·)

[½»Á÷] »ù½ðίԱ»áÓë¼ÓÄôóÎÀÉúÑо¿ÔºÀÏÄê³Õ´ôÖ¢¼°Ïà¹Ø²¡Ö¢ºÏ×÷Ñо¿ÏîÄ¿ÉêÇëÖ¸ÄÏ ÒÑÓÐ1È˲ÎÓë

2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÓë¼ÓÄôóÎÀÉúÑо¿ÔºÀÏÄê³Õ´ôÖ¢¼°Ïà¹Ø²¡Ö¢ºÏ×÷Ñо¿ÏîÄ¿ÉêÇëÖ¸ÄÏ

--------------------------------------------------------------------------------

×÷Õß:κÇÛ¡¡¡¡¡¡·¢±íʱ¼ä:2011-02-17¡¡¡¡¡¡Õª×Ô:¹ú¼ÊºÏ×÷¾Ö



¡¡¡¡Îª¼ÓÇ¿ÖмÓÁ½¹ú´óѧ¡¢Ò½Ôº¡¢Ñо¿ÔºËù»ò¸½ÊôÑо¿»ú¹¹µÄÑо¿ÈËÔ±ÔÚ½¡¿µ¿ÆÑ§»ù´¡Ñо¿ÁìÓòµÄºÏ×÷£¬´Ù½øÁ½¹ú½¡¿µ¿ÆÑ§Ñо¿µÄ½ø²½£¬Íƶ¯½¡¿µ¿ÆÑ§ÁìÓòÑо¿µÄÐÂÍ»ÆÆ£¬¸ù¾Ý2010ÄêÎÒίÓë¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÔÚË«·½¿ÆÑ§ºÏ×÷Á½ⱸÍü¼¿ò¼ÜÏÂÇ©ÊðµÄ¸½¼þII¡¶¹ØÓÚÖмÓÀÏÄê³Õ´ô¼°Ïà¹Ø²¡Ö¢ºÏ×÷Ñо¿¼Æ»®µÄʵʩϸÔò¡·£¬2011ÄêË«·½½«¹²Í¬Õ÷¼¯¡¢×ÊÖúÀÏÄê³Õ´ôÖ¢¼°Ïà¹Ø²¡Ö¢ºÏ×÷Ñо¿ÏîÄ¿£¬¾ßÌå˵Ã÷ÓëÒªÇóÈçÏ£º

¡¡¡¡Ò»¡¢ÏîĿ˵Ã÷

¡¡¡¡£¨Ò»£©×ÊÖúÏîÄ¿Êý£º²»³¬¹ý4¸öÏîÄ¿£»

¡¡¡¡£¨¶þ£©ÏîĿִÐÐÆÚ£º4Ä꣨2012.1.1¡«2015.12.31£©£¬ÉêÇëÈËÐë¸ù¾Ý»ù½ðίͳһҪÇó°´Ê±Ìá½»ÏîÄ¿½øÕ¹±¨¸æ£¬ÏîĿִÐнáÊøºóÐëÌá½»½áÌⱨ¸æ¡£

¡¡¡¡£¨Èý£©×ÊÖúÇ¿¶È£ºÖз½£º300ÍòÈËÃñ±Ò/Ï¼Ó·½£º100Íò¼ÓÔª/Ïî¡£

¡¡¡¡£¨ËÄ£©×ÊÖúÁìÓò£ºÀÏÄê³Õ´ôÖ¢¼°Ïà¹Ø²¡Ö¢¡¾ÉêÇë´úÂ룺H09¡¿£»Ö÷ÒªÑо¿·½Ïò£º

¡¡¡¡1£©Ä£ÐÍ£¨Models£©

¡¡¡¡2£©ÉúÎï±ê¼Ç¼°ÄÔ³ÉÏñ£¨Biomarkers and brain imaging£©

¡¡¡¡3£©ÒÅ´«¼°±í¹ÛÒÅ´«£¨Genetics/epigenetics£©

¡¡¡¡4£©Ò©Î↑·¢£¨Drug development£©

¡¡¡¡5£©Ñª¹ÜÐÔ³Õ´ô£¨Vascular dementia£©

¡¡¡¡6£©ÁÙ´²Ñо¿£¨Clinical studies£©

¡¡¡¡Öз½ÉêÇëÈËÐëÑ¡ÔñÉêÇë´úÂë¡°H09¡±ÌîдÖÐÎÄÉêÇëÊ飬¶ÔÓÚδ°´ÒªÇóÌîд´ËÖ¸¶¨ÉêÇë´úÂëµÄÉêÇëÊ飬½«²»ÓèÊÜÀí¡£

¡¡¡¡£¨Î壩ÆÀÉó±ê×¼£ºË«·½ÉêÇëÈËÌá³öµÄºÏ×÷Ñо¿ÏîĿӦÖ÷ÒªÎ§ÈÆÌØ¶¨¿ÆÑ§ÎÊÌ⣬ּÔÚ¸ÄÉÆÈËÃñ½¡¿µÓëÉú»îÖÊÁ¿£¬³ä·Ö·¢»ÓºÏ×÷Ë«·½µÄ֪ʶר³¤£¬Ôö½ø¿çѧ¿Æ¼äºÏ×÷£¬Í¬Ê±¹ÄÀøÇàÄê¿ÆÑÐÈËÔ±µÄ²ÎÓë¡£¼øÓÚ²»Í¬µÄÏîÄ¿²àÖØÓÚ²»Í¬µÄÑо¿·½·¨ºÍ³É¹ûת»¯Í¾¾¶£¬Ë«·½¶ÔÏîÄ¿µÄÆÀÉ󽫸ù¾Ý²»Í¬ÏîÄ¿µÄÌØµãȨºâ²Î¿¼ÏÂÁм¸Ïî±ê×¼¡£

¡¡¡¡1£©ÏîÄ¿µÄ¿ÆÑ§Ë®Æ½£»

¡¡¡¡2£©Ñо¿ÍŶӵĿÆÑÐÄÜÁ¦£»

¡¡¡¡3£©Ë«·½ÍŶÓÖ®¼äÔÚ֪ʶºÍרҵ¼¼Êõ·½ÃæµÄ»¥²¹¼°Æä½»Á÷Ëù²úÉúµÄ¸½¼ÓÖµ£»

¡¡¡¡4£©ÏîÄ¿Ñо¿³É¹ûÔÚÌá¸ßÈËÃǽ¡¿µºÍÉú»îÖÊÁ¿¼°¼õÇá¼²²¡Ëù´øÀ´µÄÉç»á¸ºµ£·½ÃæËùÆðµÄ×÷Óá£

¡¡¡¡¶þ¡¢ÉêÇëÒªÇó

¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÐë¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©£»ÐëÊÇÕýÔڳе£»ò³Ðµ£¹ý3ÄêÆÚÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄ¸ºÔðÈË£¨ÔÚ¶Á²©Ê¿¼°²©Ê¿ºó¿ÉÒÔ²ÎÓëÏîÄ¿Ñо¿£¬µ«²»µÃ×÷ΪÏîÄ¿µÄÉêÇëÈË£©¡£

¡¡¡¡£¨¶þ£©ÖмÓË«·½¿ÎÌâ×éÓ¦·Ö±ðÓɲ»³¬¹ýÁ½¸öÑо¿µ¥Î»µÄ3¡«6ÃûÑо¿ÈËÔ±×é³É£¬Ë«·½ÏîÄ¿ÉêÇëÈË×÷Ϊ¿ÎÌâÖ÷³ÖÈË£¬¸ºÔðÏîÄ¿µÄ¹ÜÀí¹¤×÷¡£

¡¡¡¡£¨Èý£©Öз½ÉêÇëÈËÐë°´ÕÕ±¾ÏîÄ¿ÉêÇëÖ¸ÄϵÄÒªÇóÏòÎÒίÌá½»ÉêÇ룻¼Ó·½ºÏ×÷ÕßÓ¦°´ÕÕCIHRµÄÒªÇóÏòCIHRÌá½»ÉêÇë¡£¶ÔÓÚµ¥·½Ìá½»µÄÉêÇ룬½«²»ÓèÊÜÀí¡£

¡¡¡¡Èý¡¢ÏÞÏî¹æ¶¨

¡¡¡¡±¾ÏîÄ¿ÊôÓÚ¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£¬Ðë×ñÑ­ÒÔÏÂÏÞÏî¹æ¶¨£º

¡¡¡¡£¨Ò»£©ÉêÇëÈË£¨²»º¬²ÎÓëÕߣ©Í¬ÄêÖ»ÄÜÉêÇë1Ïî¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£»

¡¡¡¡£¨¶þ£©±¾ÏîÄ¿¼ÆÈë¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©µÄÈËÔ±ÉêÇ루°üÀ¨ÉêÇëÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ºÍ³Ðµ££¨°üÀ¨¸ºÔðÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ÏîÄ¿×ÜÊýÏÞ3ÏîµÄ·¶Î§£»

¡¡¡¡¹ØÓÚÏÞÏî¹æ¶¨µÄÏêϸ˵Ã÷£¬Çë¼û¡¶2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîĿָÄÏ¡·¡£

¡¡¡¡ËÄ¡¢É걨˵Ã÷

¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÐëµÇ¼ISIS¿ÆÑ§»ù½ðÍøÂçϵͳ£¨http://isis.nsfc.gov.cn£©£¬ÔÚÏßÌ¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¹ú¼Ê£¨µØÇø£©ºÏ×÷Óë½»Á÷ÏîÄ¿ÉêÇëÊé¡·(ÒÔϼò³Æ¡°ÖÐÎÄÉêÇëÊ顱)¡£¾ßÌå²½ÖèÊÇ£ºÑ¡Ôñ¡°ÏîÄ¿¸ºÔðÈË¡±Óû§×éµÇ¼ϵͳ£¬½øÈëºóµã»÷¡°¹ú¼ÊºÏ×÷ÏîÄ¿ÉêÇ롱һÀ¸Öеġ°ÉêÇë¹ú¼ÊºÏ×÷ÀàÏîÄ¿¡±£¬ÔÙµã»÷¡°ÌîдÉêÇëÊ顱°´Å¥£¬ÔÚÏîÄ¿ÀàÐÍÖÐÑ¡Ôñ¡°ºÏ×÷Ñо¿¡±£¬µã»÷Õ¹¿ª×ÓÀà±ðºó£¬Ñ¡ÔñÏîÄ¿Ãû³Æ¡°NSFC-CIHRÏîÄ¿£¨Öмӣ©¡±£¬Çë°´ÕÕϵͳÌáʾÌîÈëÒ»¸öÉêÇëÈËÔø¾­Ö÷³Ö¹ý»òÕýÔÚÖ÷³ÖµÄ3ÄêÆÚÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿±àºÅ£¬Í¨¹ýϵͳÉóºËÖ®ºó£¬¼´¿É½øÈëÉêÇëÊéÌîд½çÃæ£¬ÔÚÏßÌîд²¢Ìá½»ÉêÇëÊé¡£ÖÐÎÄÉêÇëÊéÓ¦ÓëÒÔÏÂÒªÇóÌá½»µÄÓ¢ÎÄÉêÇëÊéÄÚÈÝÒ»Ö¡£

¡¡¡¡£¨¶þ£©ÉêÇëÈ˳ýÁËÌîдÌá½»ÖÐÎÄÉêÇëÊéÒÔÍ⣬ÐëÒÔ¸½¼þµÄÐÎʽÉÏ´«ÒÔÏÂÉ걨²ÄÁÏ£º

¡¡¡¡1¡¢Ó¢ÎÄÉêÇëÊ飨CHINA-CANADA Initiative on Alzheimer¡¯s Disease and Related Disorders Proposal£©£ºÖз½ÉêÇëÈËÇëÔÚ±¾ÏîÄ¿ÉêÇëÖ¸Äϸ½¼þ²¿·ÖÏÂÔØÓ¢ÎÄÉêÇëÊ飬Ñϸñ°´ÕÕÓ¢ÎÄÉêÇëÊé¸÷°æ¿é¾ßÌåµÄÒªÇó£¨ÈçÆª·ùÏÞÖÆ£©£¬Ê¹ÓÃAdobe Reader 9.0¼°ÒÔÉϰ汾µÄÈí¼þÌîдӢÎÄÉêÇëÊ飬ÆäÖС°B2. Project Description¡±°æ¿éµÄÄÚÈݲ»Äܳ¬¹ý13Ò³¡£Ë«·½ÉêÇëÈËÌá½»µÄÓ¢ÎÄÉêÇëÊéÄÚÈÝÓ¦ÍêȫһÖ£¬¸ÃÏîÄ¿µÄͬÐÐÆÀÒ齫ÒÔ´ËÓ¢ÎÄÉêÇëÊéÄÚÈÝΪ׼¡£

¡¡¡¡2¡¢¼Ó·½ºÏ×÷ÕßÏòCIHRÌá½»µÄÈ«Ì×Ó¢ÎÄÉêÇë²ÄÁÏ£¨Research Module¡¢Operating Budget ModuleºÍCommon CV°æ¿éÄÚÈÝ£©£¬Óɼӷ½ºÏ×÷ÕßÌîдÍê±Ïºó½«µç×Ó°æÌṩ¸øÖз½ÉêÇëÈË£¬²¢×÷ΪÖÐÎÄÉêÇëÊéµÄ¸½¼þÔÚISISϵͳÖÐÉÏ´«¡£

¡¡¡¡3¡¢¼Ó·½ÉêÇëÈËÇ©ÊðµÄºÏ×÷È·ÈϺ¯£¨ºÏ×÷È·ÈϺ¯ÖÐÓ¦¶Ô´ËÏîÄ¿µÄÃû³Æ¡¢ºÏ×÷µ¥Î»¼°ÈËÔ±ÐÅÏ¢ÓèÒÔÃ÷ȷ˵Ã÷£©¡£

¡¡¡¡£¨Èý£©ÔÚÏßÌîдÌá½»Íê±Ïºó£¬»¹Ðè´òÓ¡Ò»Ì×ISISϵͳÉú³ÉµÄ´øÓпÆÑ§²¿ÊÜÀíºÅµÄÖ½ÖÊÖÐÎÄÉêÇëÊ飬ǩ×Ö²¢¼Ó¸ÇÒÀÍе¥Î»¹«Õºó£¬Á¬Í¬±¾²¿·ÖµÚ£¨¶þ£©ÌõËùÁÐÉ걨²ÄÁÏÒ»²¢±¨Ë͹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðί¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦¡£

¡¡¡¡Ö½ÖÊÉêÇë²ÄÁÏÐëÓëISISϵͳÖÐÌá½»µÄµç×Ó°æÉêÇë²ÄÁÏÍêȫһÖ¡£

¡¡¡¡Îå¡¢ÏîÄ¿ÉêÇë½ØÖ¹ÈÕÆÚ£º2011Äê5ÔÂ10ÈÕ£¨Ö½ÖÊÉêÇëÊéÒÔÓÊ´ÁΪ׼£©¡£

¡¡¡¡×¢£ºÇëÉêÇëÈËÑϸñ×ñÕÕ±¾ÏîÄ¿ÉêÇëÖ¸Äϵĸ÷ÏîÒªÇóÌÉêÇ룬²»·ûºÏÉÏÊöÒªÇóµÄÉêÇ뽫ÎÞ·¨½øÈëÉóÅú³ÌÐò£¬ÊÓΪÎÞЧÉêÇë¡£¼Ó·½ÉêÇëÈËÐëµÇ¼¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÍøÕ¾°ìÀíÏîÄ¿ÉêÇëÊÖÐø¡£

¡¡¡¡Áù¡¢ÁªÏµ·½Ê½£º

¡¡¡¡£¨Ò»£©ÏîÄ¿ÉêÇëÊÂÒË£º

¡¡¡¡ÁªÏµÈË£ºÎºÇÛ  ³Â»´

¡¡¡¡µç¡¡»°£º010-62325544£»010-62327017

¡¡¡¡´«¡¡Õ棺010-62327004

¡¡¡¡µç¡¡ÓÊ£ºweiqin@nsfc.gov.cn£»chenhuai@nsfc.gov.cn

¡¡¡¡µØ¡¡Ö·£º±±¾©Êк£µíÇøË«Çå·83ºÅ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦

¡¡¡¡ÓÊ¡¡±à£º100085

¡¡¡¡£¨¶þ£©Öз½ÉêÇëÈËÔÚÏßÌîдÉêÇëÊé¹ý³ÌÖÐÈçÓм¼ÊõÎÊÌ⣬¿ÉÁªÏµÎÒίISISϵͳ¼¼ÊõÖ§³Öµç»°£º010-62317474

¡¡¡¡£¨Èý£©¼Ó·½ÉêÇëÈËÇëÓëCIHRÁªÏµ£¬ÁªÏµ·½Ê½ÈçÏ£º

¡¡¡¡1. For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

¡¡¡¡¡¡Christine Francoeur

¡¡¡¡¡¡Program Delivery Coordinator

¡¡¡¡¡¡Canadian Institutes of Health Research

¡¡¡¡¡¡Telephone: 613-952-4256

¡¡¡¡¡¡Fax: 613-954-1800

¡¡¡¡¡¡Email: christine.francoeur@cihr-irsc.gc.ca

¡¡¡¡2. For questions about this initiative and research objectives contact:

¡¡¡¡¡¡Astrid Eberhart

¡¡¡¡¡¡Associate Director, ICRSAD

¡¡¡¡¡¡Canadian Institutes of Health Research

¡¡¡¡¡¡Institute of Neurosciences, Mental Health and Addiction

¡¡¡¡¡¡Telephone: 416-231-4087

¡¡¡¡¡¡Fax: 416-231-4087

¡¡¡¡¡¡Email: astrid.eberhart@cihr-irsc.gc.ca

¸½¼þ£ºÖмÓÀÏÄê³Õ´ôÖ¢¼°Ïà¹Ø²¡Ö¢ºÏ×÷Ñо¿ÏîĿӢÎÄÉêÇëÊ飨CHINA-CANADA Initiative on Alzheimer¡¯s Disease and Related Disorders Proposal£©



Á´½ÓµØÖ·:http://www.nsfc.gov.cn/Portal0/InfoModule_396/31714.htm
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wrm


¹§Ï²¹§Ï²¡£
2Â¥2011-02-18 23:54:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ springsunyj µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-04-05 12/600 2026-04-06 10:30 by lqwchd
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +10 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-05 10/500 2026-04-06 09:35 by jp9609
[¿¼ÑÐ] 372·Ö£¬²ÄÁÏÓ뻯¹¤£¬Ò»Ö¾Ô¸ºþÄÏ´óѧ£¬Çóµ÷¼Á +3 À¶¼ãƬ 2026-04-01 3/150 2026-04-06 09:04 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 277Çóµ÷¼Á ÊýÒ»104·Ö +6 Æ¿×ÓPZ 2026-04-05 6/300 2026-04-05 20:38 by à£à£à£0119
[¿¼ÑÐ] 315Çóµ÷¼Á +5 £¦123456789 2026-04-05 5/250 2026-04-05 19:55 by nepu_uu
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +8 Á«²Ë¾ÍÊÇź°É 2026-04-03 9/450 2026-04-05 19:12 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 296Çóµ÷¼Á +3 Íô£¡£¿£¡ 2026-04-05 5/250 2026-04-05 17:38 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] 085601£¬Ò»Ö¾Ô¸Ïôó334¸´ÊÔ±»Ë¢Çóµ÷¼Á +13 ÔøÑöÖ® 2026-04-03 15/750 2026-04-04 20:13 by dongzh2009
[¿¼ÑÐ] 309·Ö085801Çóµ÷¼Á +11 MY_angel 2026-03-31 11/550 2026-04-04 19:11 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤ +19 Doleres 2026-03-31 20/1000 2026-04-04 16:44 by °¡¿¡£¡
[¿¼ÑÐ] Çóµ÷¼Á +4 ѹÁ¦??´ó 2026-04-03 4/200 2026-04-03 21:36 by à£à£à£0119
[¿¼ÑÐ] 085600ר˶²ÄÁÏÓ뻯¹¤348·ÖÇóµ÷¼Á +10 ÉÏѧÀ²£¡ 2026-04-01 11/550 2026-04-03 14:13 by °ÙÁéͯ888
[¿¼ÑÐ] 321Çóµ÷¼Á +17 y-yh 2026-04-01 20/1000 2026-04-03 12:57 by y-yh
[¿¼ÑÐ] 266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á +9 ÍÛºôºßºôºß 2026-04-02 9/450 2026-04-03 12:05 by 1753564080
[¿¼ÑÐ] 274Çóµ÷¼Á +10 Ѧ¶¨Ú̵Ļ¢¡£ 2026-04-01 10/500 2026-04-03 10:13 by tianyyysss
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-04-02 5/250 2026-04-02 21:16 by ÍÃͻͻͻ£¬
[¿¼ÑÐ] »¯Ñ§¹¤³Ìר˶324·Ö£¬Ò»Ö¾Ô¸Öйú¿óÒµ´óѧÇóµ÷¼Á +7 ¹¢¹¢1314 2026-04-01 7/350 2026-04-02 07:40 by ÉÐË®¸óÖ÷
[¿¼ÑÐ] ʡ˫һÁ÷ÖØµãÒ»±¾´óѧÕÐÊÕµ÷¼Á +4 wwwwffffff 2026-03-31 7/350 2026-04-01 15:23 by wwwwffffff
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û